Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06420960

Diagnostic Efficacy of Connected WAtch ECG Versus External Holter ECG

Rentabilité Diagnostique Des Montres connectées Par Rapport au Holter ECG Externe Dans l'Expertise Des Palpitations Fugaces Symptomatiques Sans Documentation électrocardiographique Per Critique.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
81 (estimated)
Sponsor
L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Palpitations are a frequent reason for consultation (16% of total volume) and management in the emergency department. Conventional diagnostic management in our establishment is based on a 48-hour external ECG holter, combined with a stress test if symptoms are triggered by physical activity. The diagnostic difficulty lies in the frequency and duration of this transient symptom. At the time of consultation, the patient is often asymptomatic. The initial strategy is to demonstrate an electrocardiographic trace during the attack, in order to adapt management to the chosen etiology. The HOLTER ECG is the gold standard, but it is not very cost-effective due to the infrequent and random nature of the onset of symptoms. The advent of accessible connected tools such as connected watches seems to be an interesting alternative for acquiring a per-critical trace of symptoms. They are widely adopted by the general population, with ease of use by the individual and long monitoring times. The main aim of the study is to establish the diagnostic cost-effectiveness of one or other of the two diagnostic strategies (rate of identification of the causal arrhythmia) at 6 months from the cardiological consultation.

Conditions

Interventions

TypeNameDescription
DEVICEWearing the connected watchAll patients will receive a connected watch from the research associate, along with instructions on its usage and support for creating an account on the Healtmate application using an anonymized e-mail address. They will be able to transmit up to 3 ECG tracings deemed to be per-critical. A follow-up phone call at 2- months will assess understanding of the device and its proper use, as well as the occurrence of adverse events and compliance.

Timeline

Start date
2025-04-15
Primary completion
2027-01-18
Completion
2027-02-17
First posted
2024-05-20
Last updated
2025-04-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06420960. Inclusion in this directory is not an endorsement.